Suppression of HIV-associated Macrophage Activation by a p75 Neurotrophin Receptor Ligand
Authors:
- 22 July 2021
- journal article
- research article
- Published by Springer Nature in Journal of Neuroimmune Pharmacology
- Vol. 17 (1-2) , 242-260
Abstract
Previous studies indicated that nerve growth factor (NGF) and proNGF differentially regulate the phenotype of macrophages and microglia via actions at tropomyosin receptor kinase A (TrkA) and p75 neurotrophin receptors (p75NTR), respectively. The ability of HIV gp120 and virions to induce the secretion of factors toxic to neurons was suppressed by NGF and enhanced by proNGF, suggesting the potential for neurotrophin based “anti-inflammatory” interventions. To investigate the “anti-inflammatory” potential of the p75NTR ligand, LM11A-31, we treated cultured macrophages and microglia with HIV gp120 in the presence or absence of the ligand and evaluated the morphological phenotype, intrinsic calcium signaling, neurotoxic activity and proteins in the secretome. LM11A-31 at 10 nM was able to suppress the release of neurotoxic factors from both monocyte-derived macrophages (MDM) and microglia. The protective effects correlated with a shift in morphology and a unique secretory phenotype rich in growth factors that overrode the actions of HIV gp120. The protein pattern was generally consistent with anti-inflammatory, phagocytic and tissue remodeling functions. Although the toxic factor(s) and the source of the neuroprotection were not identified, the data indicated that an increased degradation of NGF induced by HIV gp120 was likely to contribute to neuronal vulnerability. Although substantial work is still needed to reveal the functions of many proteins in the mononuclear phagocyte secretome, such as growth and differentiation factors, the data clearly indicate that the ligand LM11A-31 has excellent therapeutic potential due to its ability to induce a more protective phenotype that restricts activation by HIV. Graphical AbstractKeywords
Funding Information
- National Institutes of Health (R01 NS083164, R01 MH085606, R21 AG056924, F31 MH101019, F32 HL085025)
This publication has 66 references indexed in Scilit:
- Growth-differentiation factor-15 and functional outcome after acute ischemic strokeJournal of Neurology, 2012
- Protein changes in CSF of HIV-infected patients: evidence for loss of neuroprotectionJournal of NeuroVirology, 2011
- Increased Matrix Metalloproteinase 9 Activity in Mild Cognitive ImpairmentJournal of Neuropathology & Experimental Neurology, 2009
- Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogmaLaboratory Investigation, 2009
- Small Molecule, Non-Peptide p75NTR Ligands Inhibit Aβ-Induced Neurodegeneration and Synaptic ImpairmentPLOS ONE, 2008
- Macrophage activation and polarizationFrontiers in Bioscience-Landmark, 2008
- Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cellsBlood, 2007
- Brain‐Derived Neurotrophic Factor Prevents Human Immunodeficiency Virus Type 1 Protein gp120 Neurotoxicity in the Rat Nigrostriatal SystemAnnals of the New York Academy of Sciences, 2007
- Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascadeProceedings of the National Academy of Sciences, 2006
- Destabilization of Neuronal Calcium Homeostasis by Factors Secreted from Choroid Plexus Macrophage Cultures in Response to Feline Immunodeficiency VirusNeurobiology of Disease, 2002